Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Radnet Inc (RDNT)

Radnet Inc (RDNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
RDNT
3 of Wall Street’s Favorite Stocks We Find Risky StockStory - Wed Apr 8, 11:33PM CDT

3 of Wall Street’s Favorite Stocks We Find Risky

LADR : 10.35 (+0.19%)
SCSC : 38.19 (-1.09%)
RDNT : 58.22 (+0.80%)
RDNT
RadNet (RDNT): Buy, Sell, or Hold Post Q4 Earnings? StockStory - Tue Apr 7, 11:09PM CDT

RadNet (RDNT): Buy, Sell, or Hold Post Q4 Earnings?

RDNT : 58.22 (+0.80%)
RDNT
1 Profitable Stock to Target This Week and 2 Facing Challenges StockStory - Sun Apr 5, 11:40PM CDT

1 Profitable Stock to Target This Week and 2 Facing Challenges

CINF : 163.00 (-0.21%)
APA : 36.60 (-1.16%)
RDNT : 58.22 (+0.80%)
RDNT
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know StockStory - Fri Mar 27, 12:56PM CDT

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

ILMN : 132.26 (+1.49%)
EVH : 2.88 (+14.74%)
RGEN : 131.93 (+0.69%)
CRL : 180.56 (+0.70%)
RDNT : 58.22 (+0.80%)
RDNT
RadNet (NASDAQ:RDNT) Q4 Earnings: Leading The Testing & Diagnostics Services Pack StockStory - Thu Mar 26, 10:33PM CDT

RadNet (NASDAQ:RDNT) Q4 Earnings: Leading The Testing & Diagnostics Services Pack

RDNT : 58.22 (+0.80%)
HCA
1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds StockStory - Sun Mar 22, 11:38PM CDT

1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds

ELAN : 23.23 (-3.65%)
HCA : 488.58 (-2.02%)
RDNT : 58.22 (+0.80%)
RDNT
Why RadNet (RDNT) Shares Are Sliding Today StockStory - Wed Mar 18, 3:45PM CDT

Why RadNet (RDNT) Shares Are Sliding Today

RDNT : 58.22 (+0.80%)
RadNet, Inc. to Present Today at the KeyBanc Capital Markets Healthcare Forum GlobeNewswire - Tue Mar 17, 5:00AM CDT

LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:  RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today...

RDNT : 58.22 (+0.80%)
MYPS
3 Russell 2000 Stocks That Concern Us StockStory - Mon Mar 16, 11:31PM CDT

3 Russell 2000 Stocks That Concern Us

APAM : 37.59 (-0.71%)
MYPS : 0.4646 (+0.17%)
RDNT : 58.22 (+0.80%)
RDNT
Why RadNet (RDNT) Stock Is Up Today StockStory - Fri Mar 13, 2:40PM CDT

Why RadNet (RDNT) Stock Is Up Today

RDNT : 58.22 (+0.80%)

Barchart Exclusives

This Dividend Stock Is Becoming Too Cheap to Ignore: Should You Buy? Barchart - Wed Apr 15, 6:30PM CDT
Disney has a dividend of 1.5% and trades at a discount to the markets as well as its historical valuations. The stock looks like a good buy, particularly for value investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.